1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A β-class carbonic anhydrase (CA, EC 4.2.1.1) present in the genome of the Monogenean platyhelminth Gyrodactylus salaris, a fish parasite, GsaCAβ, has been investigated for its inhibitory effects with a panel of sulphonamides and sulfamates, some of which in clinical use. Several effective GsaCAβ inhibitors were identified, belonging to simple heterocyclic sulphonamides, the deacetylated precursors of acetazolamide and methazolamide ( K Isof 81.9–139.7 nM). Many other simple benezene sulphonamides and clinically used agents, such as acetazolamide, methazolamide, ethoxzolamide, dorzolamide, benzolamide, sulthiame and hydrochlorothiazide showed inhibition constants <1 µM. The least effective GsaCAβ inhibitors were 4,6-disubstituted-1,3-benzene disulfonamides, with K Is in the range of 16.9–24.8 µM. Although no potent GsaCAβ-selective inhibitors were detected so far, this preliminary investigation may be helpful for better understanding the inhibition profile of this parasite enzyme and for the potential development of more effective and eventually parasite-selective inhibitors.

          Related collections

          Most cited references73

          • Record: found
          • Abstract: found
          • Article: not found

          Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

          Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiological and pathological processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens. In addition to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel anti-obesity, anticancer and anti-infective drugs. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease. This article discusses the biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clinical trials.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C.

            R Khalifah (1971)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Carbonic Anhydrases and Metabolism

              Although the role of carbonic anhydrases (CAs, EC 4.2.1.1) in metabolism is well-established, pharmacological applications of this phenomenon started to be considered only recently. In organisms all over the phylogenetic tree, the seven CA genetic families known to date are involved in biosynthetic processes and pH modulation, which may influence metabolism in multiple ways, with both processes being amenable to pharmacologic intervention. CA inhibitors possess antiobesity action directly by inhibiting lipogenesis, whereas the hypoxic tumor metabolism is highly controlled by the transmembrane isoforms CA IX and XII, which contribute to the acidic extracellular environment of tumors and supply bicarbonate for their high proliferation rates. Many of the articles from this special issue deal with the role of cancer CAs in tumor metabolism and how these phenomena can be used for designing innovative antitumor therapies/imaging agents. The metabolic roles of CAs in bacteria and algae are also discussed.
                Bookmark

                Author and article information

                Journal
                J Enzyme Inhib Med Chem
                J Enzyme Inhib Med Chem
                Journal of Enzyme Inhibition and Medicinal Chemistry
                Taylor & Francis
                1475-6366
                1475-6374
                17 January 2023
                2023
                17 January 2023
                : 38
                : 1
                : 2167988
                Affiliations
                [a ]Faculty of Medicine and Health Technology, Tampere University , Tampere, Finland
                [b ]Department of Neuroscience, Psychology, Drug Research and Child’s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence , Sesto Fiorentino, Italy
                [c ]Ecology and Genetics, University of Oulu , Oulu, Finland
                [d ]Department of Biology, University of Turku , Turku, Finland
                [e ]Institute of Biotechnology, University of Helsinki , Helsinki, Finland
                [f ]Organismal and Evolutionary Biology Research Programme, University of Helsinki , Helsinki, Finland
                [g ]Fimlab Ltd, Tampere University Hospital , Tampere, Finland
                Author notes
                CONTACT Ashok Aspatwar ashok.aspatwar@ 123456tuni.fi Faculty of Medicine and Health Technology, Tampere University , Via Ugo Schiff 6, Tampere, 50019, Finland
                Claudiu T. Supuran claudiu.supuran@ 123456unifi.it Department of Neuroscience, Psychology, Drug Research and Child’s Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence , Sesto Fiorentino, Italy
                Author information
                https://orcid.org/0000-0002-6938-7835
                https://orcid.org/0000-0002-3687-8435
                https://orcid.org/0000-0001-7323-8536
                https://orcid.org/0000-0003-4262-0323
                Article
                2167988
                10.1080/14756366.2023.2167988
                9848252
                36647786
                27297725-cd3e-4b50-9d39-84f70b52329d
                © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 1, Tables: 2, Pages: 6, Words: 4118
                Categories
                Brief Report
                Brief Report

                Pharmaceutical chemistry
                carbonic anhydrase,gyrodactylus salaris,kinetics,sulphonamide inhibitors,sulfamate

                Comments

                Comment on this article